| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.6M | -95.3% |
| R&D Expense | $113.3M | +16.4% |
| SG&A Expense | $50.4M | +14.7% |
| Operating Income | -$151.1M | -219.6% |
| Pre-tax Income | -$109.0M | -173.3% |
| Income Tax | $3.6M | -93.1% |
| Net Income | -$112.6M | -216.5% |
| EPS (Basic) | -$3.15 | -215.8% |
| EPS (Diluted) | -$3.15 | -223.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $251.2M | -11.8% |
| Short-term Investments | $280.7M | -14.5% |
| Current Assets | $550.7M | -12.4% |
| Total Assets | $667.6M | -11.6% |
| Current Liabilities | $40.0M | -4.7% |
| Total Liabilities | $92.4M | +0.8% |
| Stockholders' Equity | $575.2M | -13.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$103.8M | +6.7% |
| Capital Expenditures | $3.0M | +216.2% |
| Investing Cash Flow | $72.7M | +116.3% |
| Financing Cash Flow | $1.1M | -43.9% |
| Free Cash Flow | -$106.7M | +4.8% |